Amy W. Schulman, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 8,500 shares at $240.00 ($2.0M) on 2024-06-25, disclosed to the SEC on 2024-06-27.
Scheduled sale ($2.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALNY | SELL | 2024-05-31 | $6.4M | — | Filing → |
| SQZ | BUY | 2021-12-15 | $40K | — | Filing → |
| HCII | BUY | 2021-04-14 | $0 | — | Filing → |